Tech Company Financing Transactions

Ceptyr Funding Round

On 3/31/2005, Ceptyr landed $460 thousand in financing from Arch Venture Partners.

Transaction Overview

Company Name
Announced On
3/31/2005
Transaction Type
Venture Equity
Amount
$460,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
12277 134th Ct. NE 100
Redmond, WA 98052
USA
Email Address
Overview
CEPTYR, Inc., was founded to focus on developing drugs against protein tyrosine phosphatases (PTPs), a largely unexplored domain in pharmaceutical development. We assembled the world's leading experts in this field. Excellent progress has been made in identifying compelling PTP targets, and in novel chemistry for inhibitor drugs.
Profile
Ceptyr LinkedIn Company Profile
Social Media
Ceptyr Company Twitter Account
Company News
Ceptyr News
Facebook
Ceptyr on Facebook
YouTube
Ceptyr on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
James Rathmann
  James Rathmann LinkedIn Profile  James Rathmann Twitter Account  James Rathmann News  James Rathmann on Facebook
Chief Financial Officer
Gerald McGuire
  Gerald McGuire LinkedIn Profile  Gerald McGuire Twitter Account  Gerald McGuire News  Gerald McGuire on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2005: CITTIO venture capital transaction
Next: 3/31/2005: Replication Medical venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on every notable VC transaction. VC investment data records on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary